Clean Watchlist Candidate
OLYSIO
OLYSIO carries substance and product and use-code patents, moderate complexity (3/5), and meaningful clinical competition (3/5). The listed expiry window is approximately 38 months away. Active clinical competition may compress the generic entry window.
LOE window
38months
to latest listed patent expiry (September 5, 2029)
Expiry attractiveness: 4/5
Patent profile
Substance patent (listed)
Product / formulation patent (listed)
Use-code patent (listed)
Patent count: 8
Complexity score: 3/5
Clinical competition
Score: 3/5
Active trials linked: 117
Phase 2/3 trials: 48
Higher scores indicate more trial activity for this ingredient — a proxy for competitive generic interest.
Drug overview
Active ingredient: SIMEPREVIR SODIUM
Applicant (NDA holder): JANSSEN PRODUCTS LP
Confidence: Medium